Status:
COMPLETED
Strength and Function Following Total Hip Arthroplasty
Lead Sponsor:
University of Colorado, Denver
Conditions:
Total Hip Arthroplasty
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
To determine if patients who receive an 8 week, comprehensive, multi-component rehabilitation program (CMC) have better strength and functional performance compared to a control group (CON). The inve...
Detailed Description
The participants will be enrolled and following surgery, randomized into one of two treatment groups (CMC or CON). Prior to randomization, both groups will participate in two weeks of home rehabilitat...
Eligibility Criteria
Inclusion
- receiving a total hip replacement secondary to MD diagnosed end-state osteoarthritis only
- cognitive status that allows patients to consistently comprehend and repeat back directions regarding the details of the study.
Exclusion
- HbA1c levels greater than 7% based on medical records
- neurological, vascular or cardiac problems that limit function
- moderate or severe osteoarthritis or other orthopaedic conditions in the non-operated lower extremity
- lower back pain which interferes with activities of daily living
- diagnosed disease which affects muscle function (Parkinson's, Fibromyalgia, Multiple Sclerosis)
- history of vestibular dysfunction
- body mass index greater than 40
- alcoholism or drug abuse
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT01817010
Start Date
September 1 2012
End Date
December 1 2015
Last Update
July 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Denver, Anschutz Medical Campus
Aurora, Colorado, United States, 80045